Citrulline-urea cycle in KSHV cellular transformation
KSHV 细胞转化中的瓜氨酸-尿素循环
基本信息
- 批准号:10634838
- 负责人:
- 金额:$ 54.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAbbreviationsAcquired Immunodeficiency SyndromeAmino AcidsAnimal ModelBiological ModelsCell Culture TechniquesCitric Acid CycleCitrullineConsumptionDevelopmentEnsureEnzyme InhibitionEnzymesGenesGlucoseGlutamineGoalsHerpesviridae InfectionsHumanHuman Herpesvirus 8Kaposi SarcomaMalignant NeoplasmsMediatingMesenchymal Stem CellsMetabolicMetabolic PathwayMicroRNAsModelingMorbidity - disease rateMulticentric Angiofollicular Lymphoid HyperplasiaNOS2A geneNitric OxideNitrogenNucleotidesOncogenicPathway interactionsPatientsPreventionProliferatingProteinsRegulationRoleSTAT3 geneSignal InductionSignal TransductionSignaling MoleculeSocietiesTechnologyTestingTherapeuticUp-RegulationWarburg EffectWorkaerobic glycolysisargininosuccinate synthasecancer cellcancer typecarcinogenesiscell transformationeffectiveness evaluationexpectationinnovationknockout genemetabolic profilemetaplastic cell transformationmortalitymultidisciplinarynew therapeutic targetnovelnovel therapeuticsnucleotide metabolismpharmacologicprimary effusion lymphomatherapeutic targettumortumorigenesisurea cycle
项目摘要
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the causal agent of Kaposi’s sarcoma (KS) and several other malignancies. We have discovered that, unlike most other types of cancer cells that are addicted to glucose and aerobic glycolysis, KSHV-transformed cells do not depend on glucose and have a reduced level of aerobic glycolysis. Instead, KSHV-transformed cells are addicted to glutamine. More surprisingly, glutamine is primarily shunted to the syntheses of nucleotides and amino acids. To maintain the metabolic flow and clear the toxic products, KSHV hijacks the citrulline-urea cycle by upregulating the key rate-limiting metabolic enzyme argininosuccinate synthase 1 (ASS1). Significantly, ASS1 is essential for the proliferation and survival of KSHV- transformed cells and upregulation of the citrulline-urea cycle further provides an essential STAT3 oncogenic signal by inducing nitric oxide. Our hypothesis is that KSHV encodes specific gene(s) to hijack the citrulline-urea cycle to support the proliferation and survival of KSHV-transformed cells, and hence targeting this pathway is effective for treating KSHV-induced tumors. We have developed an efficient model of KSHV-induced cellular transformation and tumorigenesis, three-dimensional (3D) culture models KSHV- transformed cells, and advanced metabolic profiling and tracing technologies, all of which are particularly useful for testing this novel hypothesis. We will examine the essential roles of ASS1 and citrulline-urea cycle for maintaining metabolic flow, clearing toxic products and activating STAT3 pathway to support KSHV-induced cellular transformation (Aim 1); determine the mechanism by which ASS1 and active citrulline-urea cycle activate the STAT3 pathway to support KSHV-induced cellular transformation (Aim 2); determine the mechanism by which KSHV upregulates ASS1 and hijacks the citrulline-urea cycle (Aim 3); and determine the therapeutic potential of targeting key enzymes in the citrulline-urea cycle for treating KSHV-induced tumorigenesis (Aim 4). The proposed project is highly significant as it will test a novel hypothesis of KSHV manipulation of a key cellular metabolic pathway using multidisciplinary innovative approaches and model systems. It is our expectations that accomplishment of this project will lead to the identification of novel cancer drivers and vulnerabilities of KSHV-induced cancers, which could provide a scientific basis for developing novel therapies.
卡波西肉瘤相关疱疹病毒 (KSHV) 是卡波西肉瘤 (KS) 和其他几种恶性肿瘤的病原体,我们发现,与大多数其他类型的癌细胞对葡萄糖和有氧糖酵解上瘾不同,KSHV 转化的细胞不会。更令人惊讶的是,KSHV 转化的细胞依赖于葡萄糖,并且有氧糖酵解水平降低。谷氨酰胺主要用于核苷酸和氨基酸的合成,为了维持代谢流并清除有毒产物,KSHV 通过上调关键限速代谢酶精氨琥珀酸合酶 1 (ASS1) 来劫持瓜氨酸-尿素循环。对于 KSHV 转化细胞的增殖和存活至关重要,瓜氨酸-尿素循环的上调进一步提供了必要的我们的假设是,KSHV 编码特定基因来劫持瓜氨酸-尿素循环,以支持 KSHV 转化细胞的增殖和存活,因此针对该途径可有效治疗 KSHV 诱导的肿瘤信号。我们开发了 KSHV 诱导的细胞转化和肿瘤发生的有效模型、KSHV 转化细胞的三维 (3D) 培养模型以及先进的代谢分析和肿瘤发生。我们将研究 ASS1 和瓜氨酸-尿素循环在维持代谢流、清除有毒产物和激活 STAT3 途径以支持 KSHV 诱导的细胞转化方面的重要作用。 );确定 ASS1 和活性瓜氨酸-尿素循环激活 STAT3 途径以支持 KSHV 诱导的细胞转化的机制(目标 2);上调 ASS1 并劫持瓜氨酸-尿素循环(目标 3);并确定针对瓜氨酸-尿素循环中的关键酶治疗 KSHV 诱导的肿瘤发生的治疗潜力(目标 4)。使用多学科创新方法和模型系统,KSHV 操纵关键细胞代谢途径的新假设我们期望该项目的完成将导致新的癌症驱动因素的识别。以及 KSHV 诱发的癌症的脆弱性,这可以为开发新疗法提供科学依据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shou-Jiang Gao其他文献
Shou-Jiang Gao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shou-Jiang Gao', 18)}}的其他基金
Impact of microbiota on AIDS-Kaposi’s sarcoma development and therapy
微生物群对艾滋病-卡波西肉瘤发展和治疗的影响
- 批准号:
10753890 - 财政年份:2023
- 资助金额:
$ 54.05万 - 项目类别:
Regulation of KSHV replication by N6-methyladenosine (m6A) - Diversity Supplement
N6-甲基腺苷 (m6A) 对 KSHV 复制的调节 - Diversity Supplement
- 批准号:
10533427 - 财政年份:2022
- 资助金额:
$ 54.05万 - 项目类别:
HISTONE MODIFIERS IN ORAL KSHV INFECTION AND MALIGNANCIES
口腔 KSHV 感染和恶性肿瘤中的组蛋白修饰剂
- 批准号:
9756364 - 财政年份:2018
- 资助金额:
$ 54.05万 - 项目类别:
KSHV microRNAs in tumor invasion and angiogenesis
KSHV microRNA 在肿瘤侵袭和血管生成中的作用
- 批准号:
9906178 - 财政年份:2017
- 资助金额:
$ 54.05万 - 项目类别:
KSHV microRNAs in tumor invasion and angiogenesis
KSHV microRNA 在肿瘤侵袭和血管生成中的作用
- 批准号:
9243868 - 财政年份:2017
- 资助金额:
$ 54.05万 - 项目类别:
KSHV microRNAs in tumor invasion and angiogenesis
KSHV microRNA 在肿瘤侵袭和血管生成中的作用
- 批准号:
10264784 - 财政年份:2017
- 资助金额:
$ 54.05万 - 项目类别:
Targeting KSHV malignancies and persistent infection
针对 KSHV 恶性肿瘤和持续感染
- 批准号:
8943348 - 财政年份:2015
- 资助金额:
$ 54.05万 - 项目类别:
HISTONE MODIFIERS IN ORAL KSHV INFECTION AND MALIGNANCIES
口腔 KSHV 感染和恶性肿瘤中的组蛋白修饰剂
- 批准号:
9108377 - 财政年份:2015
- 资助金额:
$ 54.05万 - 项目类别:
HISTONE MODIFIERS IN ORAL KSHV INFECTION AND MALIGNANCIES
口腔 KSHV 感染和恶性肿瘤中的组蛋白修饰剂
- 批准号:
9257374 - 财政年份:2015
- 资助金额:
$ 54.05万 - 项目类别:
KSHV microRNAs in cellular transformation and tumorigenesis
KSHV microRNA 在细胞转化和肿瘤发生中的作用
- 批准号:
8728172 - 财政年份:2013
- 资助金额:
$ 54.05万 - 项目类别:
相似海外基金
Understanding Health Inequities at the Intersection of the HIV and substance use epidemics across racial/ethnic and other underserved populations
了解不同种族/族裔和其他服务不足人群中艾滋病毒和药物滥用流行病交汇处的健康不平等
- 批准号:
10738418 - 财政年份:2023
- 资助金额:
$ 54.05万 - 项目类别:
HIV and Substance Use Cohort Coordinating Center for Emerging and High Impact Scientific Cross Cohort Studies: HIV SUCCESS
艾滋病毒和药物使用队列协调中心新兴和高影响科学跨队列研究:艾滋病毒成功
- 批准号:
10676432 - 财政年份:2023
- 资助金额:
$ 54.05万 - 项目类别:
Occidiofungin as a new lead against the enteric AIDS-OI cryptosporidium
Occidiofungin 是对抗肠道 AIDS-OI 隐孢子虫的新药物
- 批准号:
10380785 - 财政年份:2021
- 资助金额:
$ 54.05万 - 项目类别:
Occidiofungin as a new lead against the enteric AIDS-OI cryptosporidium
Occidiofungin 是对抗肠道 AIDS-OI 隐孢子虫的新药物
- 批准号:
10254631 - 财政年份:2021
- 资助金额:
$ 54.05万 - 项目类别:
Colorado Summer Institute in Biostatistics (CoSIBS)
科罗拉多州夏季生物统计学研究所 (CoSIBS)
- 批准号:
9888414 - 财政年份:2019
- 资助金额:
$ 54.05万 - 项目类别: